These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Therapy-induced Deletion in 11q23 Leading to Fusion of Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897 [TBL] [Abstract][Full Text] [Related]
23. Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation. Liu J; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Cheng YF; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD Ann Hematol; 2021 May; 100(5):1267-1281. PubMed ID: 33712867 [TBL] [Abstract][Full Text] [Related]
25. Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in Adriaanse FRS; Schneider P; Arentsen-Peters STCJM; Fonseca AMND; Stutterheim J; Pieters R; Zwaan CM; Stam RW Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892207 [TBL] [Abstract][Full Text] [Related]
26. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia. Tandon S; Shago M; Davidson S; Kanwar N; Fuligni F; Shlien A; Whitlock J; Villani A; Abla O Cancer Genet; 2020 Oct; 248-249():31-33. PubMed ID: 32992102 [TBL] [Abstract][Full Text] [Related]
27. Identification of a Cryptic Insertion ins(11;X)(q23;q28q12) Resulting in a KMT2A-FLNA Fusion in a 13-Month-Old Child with Acute Myelomonocytic Leukemia. Lentes J; Thomay K; Schneider DT; Bernbeck B; Reinhardt D; Marschalek R; Meyer C; Schlegelberger B; Göhring G Cytogenet Genome Res; 2016; 150(3-4):281-286. PubMed ID: 28253492 [TBL] [Abstract][Full Text] [Related]
28. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood van Weelderen RE; Klein K; Harrison CJ; Jiang Y; Abrahamsson J; Arad-Cohen N; Bart-Delabesse E; Buldini B; De Moerloose B; Dworzak MN; Elitzur S; Fernández Navarro JM; Gerbing RB; Goemans BF; de Groot-Kruseman HA; Guest E; Ha SY; Hasle H; Kelaidi C; Lapillonne H; Leverger G; Locatelli F; Masetti R; Miyamura T; Norén-Nyström U; Polychronopoulou S; Rasche M; Rubnitz JE; Stary J; Tierens A; Tomizawa D; Zwaan CM; Kaspers GJL J Clin Oncol; 2023 Jun; 41(16):2963-2974. PubMed ID: 36996387 [TBL] [Abstract][Full Text] [Related]
29. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression. Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595 [TBL] [Abstract][Full Text] [Related]
30. Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia. Ikeda J; Shiba N; Tsujimoto SI; Yoshida M; Nakabayashi K; Ogata-Kawata H; Okamura K; Takeuchi M; Osumi T; Tomizawa D; Hata K; Kiyokawa N; Ito S; Kato M Genes Chromosomes Cancer; 2019 Sep; 58(9):669-672. PubMed ID: 30869817 [TBL] [Abstract][Full Text] [Related]
31. Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23); Du J; Chisholm KM; Tsuchiya K; Leger K; Lee BM; Rutledge JC; Paschal CR; Summers C; Xu M Pediatr Dev Pathol; 2021; 24(4):378-382. PubMed ID: 33749383 [TBL] [Abstract][Full Text] [Related]
32. Updates in Górecki M; Kozioł I; Kopystecka A; Budzyńska J; Zawitkowska J; Lejman M Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979800 [TBL] [Abstract][Full Text] [Related]
33. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group. Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545 [TBL] [Abstract][Full Text] [Related]
34. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial. Shiba N; Ohki K; Kobayashi T; Hara Y; Yamato G; Tanoshima R; Ichikawa H; Tomizawa D; Park MJ; Shimada A; Sotomatsu M; Arakawa H; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y Br J Haematol; 2016 Feb; 172(4):581-91. PubMed ID: 26684393 [TBL] [Abstract][Full Text] [Related]
35. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study. de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single-institution experience. Konoplev S; Wang X; Tang G; Li S; Wang W; Xu J; Pierce SA; Jia F; Jorgensen JL; Ravandi F; Issa GC; Medeiros LJ; Wang SA Cytometry B Clin Cytom; 2022 Mar; 102(2):123-133. PubMed ID: 34964255 [TBL] [Abstract][Full Text] [Related]
37. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Balgobind BV; Raimondi SC; Harbott J; Zimmermann M; Alonzo TA; Auvrignon A; Beverloo HB; Chang M; Creutzig U; Dworzak MN; Forestier E; Gibson B; Hasle H; Harrison CJ; Heerema NA; Kaspers GJ; Leszl A; Litvinko N; Nigro LL; Morimoto A; Perot C; Pieters R; Reinhardt D; Rubnitz JE; Smith FO; Stary J; Stasevich I; Strehl S; Taga T; Tomizawa D; Webb D; Zemanova Z; Zwaan CM; van den Heuvel-Eibrink MM Blood; 2009 Sep; 114(12):2489-96. PubMed ID: 19528532 [TBL] [Abstract][Full Text] [Related]
38. The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes. Liu XX; Pan XA; Gao MG; Kong J; Jiang H; Chang YJ; Zhang XH; Wang Y; Liu KY; Chen Z; Zhao XS; Huang XJ Int J Lab Hematol; 2023 Apr; 45(2):195-203. PubMed ID: 36358022 [TBL] [Abstract][Full Text] [Related]
39. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Sakhdari A; Tang Z; Ok CY; Bueso-Ramos CE; Medeiros LJ; Huh YO Cancer Genet; 2019 Oct; 238():18-22. PubMed ID: 31425921 [TBL] [Abstract][Full Text] [Related]
40. High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome. Balgobind BV; Zwaan CM; Reinhardt D; Arentsen-Peters TJ; Hollink IH; de Haas V; Kaspers GJ; de Bont ES; Baruchel A; Stary J; Meyer C; Marschalek R; Creutzig U; den Boer ML; Pieters R; van den Heuvel-Eibrink MM Leukemia; 2010 Dec; 24(12):2048-55. PubMed ID: 20861917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]